Cabaletta Bio Inc
NASDAQ:CABA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akiba Holdings Co Ltd
TSE:6840
|
JP |
|
K
|
Kemira Oyj
XBER:KEM
|
FI |
|
Toast Inc
NYSE:TOST
|
US |
|
Rigaku Holdings Corp
TSE:268A
|
JP |
|
Top KingWin Ltd
NASDAQ:WAI
|
CN |
|
O
|
Osisko Development Corp
NYSE:ODV
|
CA |
|
Ninestar Corp
SZSE:002180
|
CN |
|
S
|
Sunil Industries Ltd
BSE:521232
|
IN |
|
METISA Metalurgica Timboense SA
BOVESPA:MTSA4
|
BR |
|
V
|
Visa Steel Ltd
NSE:VISASTEEL
|
IN |
|
Usha Martin Education And Solutions Ltd
NSE:UMESLTD
|
IN |
|
D
|
Delta Israel Brands Ltd
TASE:DLTI
|
IL |
|
A
|
Agricola Nacional SAC e I
SGO:ANASAC
|
CL |
|
I
|
ICP Israel Citrus Plantations Ltd
TASE:CTPL1
|
IL |
During the last 3 months Cabaletta Bio Inc insiders bought 296.2k USD , and have not sold any shares. The stock price has increased by 57% over this period (open performance analysis).
The last transaction was made on
Jan 21, 2026
by
Simon Mark
, who
bought
25.3k USD
worth of 
CABA shares.
During the last 3 months Cabaletta Bio Inc insiders bought 296.2k USD , and have not sold any shares. The stock price has increased by 57% over this period (open performance analysis).
The last transaction was made on
Jan 21, 2026
by
Simon Mark
, who
bought
25.3k USD
worth of CABA shares.
Cabaletta Bio Inc
Glance View
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. The company is headquartered in Philadelphia, Pennsylvania and currently employs 53 full-time employees. The company went IPO on 2019-10-25. The firm is focused on discovery and development of engineered T-cell therapies for B cell-mediated autoimmune diseases. The T cells are designed to selectively bind and eliminate B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. The firm's lead CAAR T cell product candidate is designed based on chimeric antigen receptor (CAR), and its T cell technology has been developed and is marketed for the treatment of B cell cancers. The firm has discovered and developed four product candidates, including its lead product candidate, to potentially treat patients with mucosal pemphigus vulgaris (mPV), and three additional product candidates that have demonstrated specific and selective target engagement in vitro. Its product pipelines include DSG3-CAART, DSG3/1-CAART, Musk-CAART and FVIII-CAART.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
